Amneal Pharmaceuticals (AMRX) Debt Ratio (2017 - 2026)

Amneal Pharmaceuticals has reported Debt Ratio for 10 years, with the latest figure at 0.71 in Q2 2026.

• On a quarterly basis, Debt Ratio fell 1.92% year-over-year to 0.71 in Q2 2026; TTM through Jun 2026 was 0.71, a 1.92% decrease from a year earlier, with the FY2025 full-year figure at 0.7, down 5.96% from the prior year.
• Debt Ratio was 0.71 for Q2 2026 at Amneal Pharmaceuticals, down from 0.73 in the prior quarter.
• The five-year high for Debt Ratio was 0.76 in Q2 2024, with the low at 0.68 in Q2 2022.
• Average Debt Ratio over 5 years is 0.72, with a median of 0.72 recorded in 2025.
• The sharpest annual moves came in 2023 and 2025: Debt Ratio gained 6.73% in 2023, then declined 5.96% in 2025.
• Over 5 years, Debt Ratio stood at 0.71 in 2022, then rose by 5.93% to 0.75 in 2023, then dropped by 0.4% to 0.75 in 2024, then declined by 5.96% to 0.7 in 2025, then increased by 0.87% to 0.71 in 2026.
• The last three Debt Ratio figures came in at 0.71 (Q2 2026), 0.73 (Q1 2026), and 0.7 (Q4 2025), per Business Quant data.